Copyright Reports & Markets. All rights reserved.

Global IVIG Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 IVIG Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global IVIG Market Size Growth Rate by Product
      • 1.4.2 Injection
      • 1.4.3 Lyophilized Powder
    • 1.5 Market by End User
      • 1.5.1 Global IVIG Market Size Growth Rate by End User
      • 1.5.2 Multiple Sclerosis (MS)
      • 1.5.3 Myasthenia Gravis (MG)
      • 1.5.4 Multifocal Motor Neuropathy (MMN)
      • 1.5.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
      • 1.5.6 Dermatomyositis
      • 1.5.7 Polymyositis
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global IVIG Market Size
      • 2.1.1 Global IVIG Revenue 2014-2025
      • 2.1.2 Global IVIG Sales 2014-2025
    • 2.2 IVIG Growth Rate by Regions
      • 2.2.1 Global IVIG Sales by Regions
      • 2.2.2 Global IVIG Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 IVIG Sales by Manufacturers
      • 3.1.1 IVIG Sales by Manufacturers
      • 3.1.2 IVIG Sales Market Share by Manufacturers
      • 3.1.3 Global IVIG Market Concentration Ratio (CR5 and HHI)
    • 3.2 IVIG Revenue by Manufacturers
      • 3.2.1 IVIG Revenue by Manufacturers (2014-2019)
      • 3.2.2 IVIG Revenue Share by Manufacturers (2014-2019)
    • 3.3 IVIG Price by Manufacturers
    • 3.4 IVIG Manufacturing Base Distribution, Product Types
      • 3.4.1 IVIG Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers IVIG Product Type
      • 3.4.3 Date of International Manufacturers Enter into IVIG Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global IVIG Sales by Product
    • 4.2 Global IVIG Revenue by Product
    • 4.3 IVIG Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global IVIG Breakdown Data by End User

    6 North America

    • 6.1 North America IVIG by Countries
      • 6.1.1 North America IVIG Sales by Countries
      • 6.1.2 North America IVIG Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America IVIG by Product
    • 6.3 North America IVIG by End User

    7 Europe

    • 7.1 Europe IVIG by Countries
      • 7.1.1 Europe IVIG Sales by Countries
      • 7.1.2 Europe IVIG Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe IVIG by Product
    • 7.3 Europe IVIG by End User

    8 Asia Pacific

    • 8.1 Asia Pacific IVIG by Countries
      • 8.1.1 Asia Pacific IVIG Sales by Countries
      • 8.1.2 Asia Pacific IVIG Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific IVIG by Product
    • 8.3 Asia Pacific IVIG by End User

    9 Central & South America

    • 9.1 Central & South America IVIG by Countries
      • 9.1.1 Central & South America IVIG Sales by Countries
      • 9.1.2 Central & South America IVIG Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America IVIG by Product
    • 9.3 Central & South America IVIG by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa IVIG by Countries
      • 10.1.1 Middle East and Africa IVIG Sales by Countries
      • 10.1.2 Middle East and Africa IVIG Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa IVIG by Product
    • 10.3 Middle East and Africa IVIG by End User

    11 Company Profiles

    • 11.1 Green Cross
      • 11.1.1 Green Cross Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Green Cross IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Green Cross IVIG Products Offered
      • 11.1.5 Green Cross Recent Development
    • 11.2 BSV
      • 11.2.1 BSV Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 BSV IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 BSV IVIG Products Offered
      • 11.2.5 BSV Recent Development
    • 11.3 Hualan Bio
      • 11.3.1 Hualan Bio Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Hualan Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Hualan Bio IVIG Products Offered
      • 11.3.5 Hualan Bio Recent Development
    • 11.4 RAAS
      • 11.4.1 RAAS Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 RAAS IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 RAAS IVIG Products Offered
      • 11.4.5 RAAS Recent Development
    • 11.5 YUAN DA SHUYANG
      • 11.5.1 YUAN DA SHUYANG Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 YUAN DA SHUYANG IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 YUAN DA SHUYANG IVIG Products Offered
      • 11.5.5 YUAN DA SHUYANG Recent Development
    • 11.6 Kangbao Bio
      • 11.6.1 Kangbao Bio Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Kangbao Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Kangbao Bio IVIG Products Offered
      • 11.6.5 Kangbao Bio Recent Development
    • 11.7 Tiantan Bio
      • 11.7.1 Tiantan Bio Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Tiantan Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Tiantan Bio IVIG Products Offered
      • 11.7.5 Tiantan Bio Recent Development
    • 11.8 Taibang Bio
      • 11.8.1 Taibang Bio Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Taibang Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Taibang Bio IVIG Products Offered
      • 11.8.5 Taibang Bio Recent Development
    • 11.9 Weiguang Bio
      • 11.9.1 Weiguang Bio Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Weiguang Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Weiguang Bio IVIG Products Offered
      • 11.9.5 Weiguang Bio Recent Development
    • 11.10 SIBP
      • 11.10.1 SIBP Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 SIBP IVIG Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 SIBP IVIG Products Offered
      • 11.10.5 SIBP Recent Development
    • 11.11 TONROL
    • 11.12 RUIDE Bio
    • 11.13 BOYA Bio
    • 11.14 RUIDE Bio
    • 11.15 Xinxing Medicine
    • 11.16 Weilun Bio
    • 11.17 WIBP

    12 Future Forecast

    • 12.1 IVIG Market Forecast by Regions
      • 12.1.1 Global IVIG Sales Forecast by Regions 2019-2025
      • 12.1.2 Global IVIG Revenue Forecast by Regions 2019-2025
    • 12.2 IVIG Market Forecast by Product
      • 12.2.1 Global IVIG Sales Forecast by Product 2019-2025
      • 12.2.2 Global IVIG Revenue Forecast by Product 2019-2025
    • 12.3 IVIG Market Forecast by End User
    • 12.4 North America IVIG Forecast
    • 12.5 Europe IVIG Forecast
    • 12.6 Asia Pacific IVIG Forecast
    • 12.7 Central & South America IVIG Forecast
    • 12.8 Middle East and Africa IVIG Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 IVIG Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global IVIG market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the IVIG market based on company, product type, end user and key regions.

      This report studies the global market size of IVIG in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of IVIG in these regions.
      This research report categorizes the global IVIG market by top players/brands, region, type and end user. This report also studies the global IVIG market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Green Cross
      BSV
      Hualan Bio
      RAAS
      YUAN DA SHUYANG
      Kangbao Bio
      Tiantan Bio
      Taibang Bio
      Weiguang Bio
      SIBP
      TONROL
      RUIDE Bio
      BOYA Bio
      RUIDE Bio
      Xinxing Medicine
      Weilun Bio
      WIBP

      Market size by Product
      Injection
      Lyophilized Powder
      Market size by End User
      Multiple Sclerosis (MS)
      Myasthenia Gravis (MG)
      Multifocal Motor Neuropathy (MMN)
      Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
      Dermatomyositis
      Polymyositis

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global IVIG market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of IVIG market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global IVIG companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of IVIG submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of IVIG are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of IVIG market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now